Michael Halank

Michael Halank

Dresden, SN, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 138 publications

Efficacy and Safety of Riociguat in Early Pulmonary Vascular Disease: A Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2a Trial.

Efficacy and Safety of Riociguat in Early Pulmonary Vascular Disease: A Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2a Trial.

Journal: Chest

Published: March 30, 2026

Treatment Algorithm of Pulmonary Arterial Hypertension

Treatment Algorithm of Pulmonary Arterial Hypertension

Journal: Pneumologie (Stuttgart, Germany)

Published: October 06, 2025

Chronic Thromboembolic Pulmonary Hypertension

Chronic Thromboembolic Pulmonary Hypertension

Journal: Pneumologie (Stuttgart, Germany)

Published: October 06, 2025

Pulmonary Hypertension Associated with Lung Diseases

Pulmonary Hypertension Associated with Lung Diseases

Journal: Pneumologie (Stuttgart, Germany)

Published: October 06, 2025

Functional characterisation of KCNA5 gene variants linked to pulmonary arterial hypertension.

Functional characterisation of KCNA5 gene variants linked to pulmonary arterial hypertension.

Journal: The European respiratory journal

Published: October 02, 2025

Add-on therapy with parenteral prostacyclin analogues in patients with pulmonary arterial hypertension: Insights from the COMPERA registry.

Add-on therapy with parenteral prostacyclin analogues in patients with pulmonary arterial hypertension: Insights from the COMPERA registry.

Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Published: August 31, 2025

Presurgical evaluation of adult thorax-surgery patients with oncologically resectable tumours - a joint recommendation of DGAI, DGT and DGP

Presurgical evaluation of adult thorax-surgery patients with oncologically resectable tumours - a joint recommendation of DGAI, DGT and DGP

Journal: Pneumologie (Stuttgart, Germany)

Published: August 08, 2025

Title Not Found

Title Not Found

Journal: Zentralblatt fur Chirurgie

Published: August 08, 2025

Hemodynamics and Phosphodiesterase-5 Inhibitor Treatment Associated with Survival in Pulmonary Hypertension in Interstitial Lung Disease: A PVRI GoDeep Meta-Registry Analysis.

Hemodynamics and Phosphodiesterase-5 Inhibitor Treatment Associated with Survival in Pulmonary Hypertension in Interstitial Lung Disease: A PVRI GoDeep Meta-Registry Analysis.

Journal: American journal of respiratory and critical care medicine

Published: August 07, 2025

Preoperative respiratory training with incentive spirometry for the prevention of pulmonary complications after liver surgery- a randomized pilot trial (PreSpi Trial).

Preoperative respiratory training with incentive spirometry for the prevention of pulmonary complications after liver surgery- a randomized pilot trial (PreSpi Trial).

Journal: Langenbeck's archives of surgery

Published: May 05, 2025

Safety and efficacy of upfront triple therapy including parenteral treprostinil compared to double oral therapy in PAH (TripleTRE): study protocol for a randomised trial.

Safety and efficacy of upfront triple therapy including parenteral treprostinil compared to double oral therapy in PAH (TripleTRE): study protocol for a randomised trial.

Journal: ERJ open research

Published: April 03, 2025

Correction to: Tadalafil for Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension in Patients With Heart Failure and Preserved Ejection Fraction: A Randomized Controlled Phase 3 Study.

Correction to: Tadalafil for Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension in Patients With Heart Failure and Preserved Ejection Fraction: A Randomized Controlled Phase 3 Study.

Journal: Circulation

Published: March 17, 2025

Showing 1-12 of 138

Last Updated: 09/26/2026